Global effort to develop Disease X vaccine begins
Dataconomy
AUGUST 8, 2023
In the aftermath of the global trauma of COVID-19, humanity may be faced with a new potential threat: Disease X. In collaboration with scholars and the private sector, this location stands as the sole facility in the UK capable of developing a Disease X vaccine from conception to completion. billion (£1.15
Let's personalize your content